NasdaqCM - Delayed Quote USD
Phio Pharmaceuticals Corp. (PHIO)
2.5500
+0.0800
+(3.24%)
At close: June 11 at 4:00:00 PM EDT
2.5500
0.00
(0.00%)
After hours: June 11 at 7:52:02 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-6,376
-7,112
-10,749
-12,129
-11,858
Investing Cash Flow
6
8
-5
-121
-51
Financing Cash Flow
13,173
3,996
7,413
-26
21,722
End Cash Position
13,278
5,382
8,490
11,831
24,107
Interest Paid Supplemental Data
12
13
11
--
8
Capital Expenditure
--
-1
-5
-121
-51
Issuance of Capital Stock
10,495
4,002
7,452
2
19,577
Issuance of Debt
--
--
--
--
0
Repayment of Debt
--
--
--
--
0
Repurchase of Capital Stock
--
-1
-13
0
--
Free Cash Flow
-6,379
-7,113
-10,754
-12,250
-11,909
12/31/2021 - 5/10/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SILO Silo Pharma, Inc.
0.5900
+0.51%
ELAB PMGC Holdings Inc.
2.1900
+2.34%
WINT Windtree Therapeutics, Inc.
0.6998
-12.51%
SCNI Scinai Immunotherapeutics Ltd.
2.3800
-7.03%
HOTH Hoth Therapeutics, Inc.
1.3200
+5.60%
GLYC GlycoMimetics, Inc.
0.1660
-2.58%
EYEN Eyenovia, Inc.
3.3700
-17.40%
LIMN Liminatus Pharma, Inc.
11.11
-50.45%
SGMT Sagimet Biosciences Inc.
6.19
+4.21%
SNPX Synaptogenix, Inc.
5.09
+45.43%